Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke

Abstract

This prematurely terminated trial has demonstrated the potential efficiency of a novel design in selecting a propitious dose for future study of a new thrombolytic agent for acute stroke. Given the truncation of the trial, no convincing conclusions can be made about the promise of future study of tenecteplase in acute stroke.

References

Page 1

	Year	Citations
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Harold P. Adams, Birgitte H. Bendixen, L. Jaap Kappelle, Stroke	1993	12K
Interobserver agreement for the assessment of handicap in stroke patients. John C. van Swieten, Peter J. Koudstaal, Marieke C. Visser, Stroke DisabilityCerebrovascular DiseaseNeurological RehabilitationStroke RehabilitationStroke	1988	6.3K
Guidelines for the Early Management of Adults With Ischemic Stroke Harold P. Adams, Gregory del Zoppo, Mark J. Alberts, Stroke	2007	2.5K
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial Frans Van de Werf The Lancet ThrombosisRadiologyCardiovascular DiseaseMyocardial InfarctionCoronary Artery Disease	1999	876
A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke E. Clarke Haley, Patrick D. Lyden, Karen C. Johnston, Stroke	2005	220
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology Harold P. Adams, Gregory del Zoppo, Mark J. Alberts, Cerebrovascular DiseaseThrombosisStroke RehabilitationStrokeVascular Surgery	2007	213
Survey of Emergency Physicians About Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Devin L. Brown, William G. Barsan, Lynda D. Lisabeth, Annals of Emergency Medicine ThrombosisCardiovascular DiseaseIschemic StrokeMedicineAcute Ischemic Stroke	2005	170
Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke Devin L. Brown, Karen C. Johnston, Douglas P. Wagner, Stroke	2003	158
NIHSS Training and Certification Using a New Digital Video Disk Is Reliable Patrick D. Lyden, Rema Raman, Lin Liu, Stroke	2005	135

Page 1